SCHEMBL2528804

SCHEMBL2528804

C=CCOC(CC)(OCC=C)N(C)C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3150356 0.72
SCHEMBL7938723 0.70 MEN1 (0.33) MEN1POLBKMT2A
SCHEMBL2383002 0.69
SCHEMBL28014350 0.69 MEN1 (0.32) MEN1POLBKMT2A
SCHEMBL10824758 0.69 TSHR (0.35) MEN1POLBKMT2A
SCHEMBL10919175 0.69 MEN1 (0.32) MEN1POLBKMT2A
SCHEMBL2142744 0.67
SCHEMBL2479662 0.67 MEN1 (0.35) MEN1POLBKMT2A
SCHEMBL3417372 0.67 TSHR (0.31) MEN1POLBKMT2A
SCHEMBL5561602 0.65 MEN1 (0.30) MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122760-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS THOMPSON, PATRICK R. 2012-05-17 US disclosed
US-8034977-B2 Lipids for transfection of nucleic acids MOLECULAR TRANSFER, INC. (US) 2011-10-11 US disclosed
US-20090215067-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS MOLECULAR TRANSFER, INC. (US) 2009-08-27 US disclosed
US-7531693-B2 Lipids for transfection of nucleic acids MOLECULAR TRANSFER, INC. (US) 2009-05-12 US disclosed
EP-1628647-A4 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS MOLECULAR TRANSFER INC (US) 2007-10-24 EP disclosed
EP-1628647-A2 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS Molecular Transfer, Inc. (US) 2006-03-01 EP disclosed
US-20050014962-A1 Novel lipids for transfection of nucleic acids THOMPSON AND PATRICIA A THOMPSON AS TRUSTEES OF THE THOMPSON FAMILY TRUST DATED AUGUST 27 2002, JOHN D. 2005-01-20 US disclosed
WO-2004105697-A2 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS MOLECULAR TRANSFER, INC. (US) 2004-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014962-A1 Novel lipids for transfection of nucleic acids ABHD16A, MBOAT7, NPC1L1 MEN1 2648/4885POLB 463/4885KMT2A 3361/4885
US-20090215067-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS ABHD16A, MBOAT7, NPC1L1 MEN1 2648/4885POLB 463/4885KMT2A 3361/4885
US-20120122760-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS ABHD16A, MBOAT7, NPC1L1 MEN1 2648/4885POLB 463/4885KMT2A 3361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.